Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
about
Applications of metabolomics in cancer researchUnderstanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironmentAn Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS AnalysisImaging metabolic heterogeneity in cancerMolecular Mechanisms and Metabolomics of Natural Polyphenols Interfering with Breast Cancer MetastasisIdentification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancerApplication of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in ratsPlasma free amino acid profiling of five types of cancer patients and its application for early detectionProteomics and biomarkers in clinical trials for drug developmentInduction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.Clustering Based on Periodicity in High-Throughput Time Course Data.Kernel approaches for differential expression analysis of mass spectrometry-based metabolomics data.High quality metabolomic data for Chlamydomonas reinhardtii.Extraction of pure components from overlapped signals in gas chromatography-mass spectrometry (GC-MS)Metabolic profiling reveals key metabolic features of renal cell carcinoma.Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.Multivariate classification of urine metabolome profiles for breast cancer diagnosisCapillary electrophoresis with electrospray ionization mass spectrometric detection for single-cell metabolomics.Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis.Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.Differential regulations of blood pressure and perturbed metabolism by total ginsenosides and conventional antihypertensive agents in spontaneously hypertensive rats.Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA)Metabolomics of ApcMin/+ mice genetically susceptible to intestinal cancerMass spectrometry methodology in lipid analysis.Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.Wavelet- and Fourier-transform-based spectrum similarity approaches to compound identification in gas chromatography/mass spectrometry.Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.Early detection of recurrent breast cancer using metabolite profiling.Improved drug therapy: triangulating phenomics with genomics and metabolomics.Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.Proteomics as a guiding tool for more effective personalized therapy.Metabolic profiling for detection of Staphylococcus aureus infection and antibiotic resistance.OVCAR-3 spheroid-derived cells display distinct metabolic profilesSerum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.Towards imaging metabolic pathways in tissues.A distinct metabolic signature predicts development of fasting plasma glucose.Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass SpectrometryMetabolic signatures differentiate ovarian from colon cancer cell lines.Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach
P2860
Q24600728-BC0516F3-1222-4D1B-87EE-384B05ECB047Q26852398-EA133159-DB00-4CD6-9E56-B71E9C34B312Q27320823-526F5B02-A64C-42A0-B7B9-B48ACF2E9820Q28076500-4C7F44C3-B08C-4B08-8E63-C87F401F3E7DQ28076953-3835AF67-E1AF-47A9-9740-96D56EBFC0FAQ28478197-A2DED3D2-EE09-404E-BC27-ED28F03C9DADQ28656449-FB08FCCA-E1A5-466C-86E3-F45AF434179BQ28740654-639BBED5-C00C-4917-B3F2-101AA2815BF1Q30402667-7856A17A-9C08-4B02-ADE7-650E6680365EQ30442799-D24F8362-A581-4F77-A19F-61F015BCF9A3Q30647206-52F54550-34F8-439F-8E1A-3B3B6FCC54F1Q30935991-C688C9BB-D70D-44DC-B093-DF0CA86D1E14Q31153825-DD4B54D0-885C-47A1-A247-B6521D99AA96Q33509650-042379C5-BEB9-4F8A-B4B3-F8B7470CEC6AQ33511655-F4ACFC88-E759-4549-A8BF-2800FBE218EBQ33555354-3AEF046C-6D06-4203-AE17-6809D232774EQ33560536-84114433-4523-4973-8025-1233E25CFC8BQ33606017-CBF72EFF-DE31-4714-9CD6-EFCD911E0500Q33699851-6C448883-442F-48D4-A516-5018F7849493Q33769607-D2655AA6-966F-41E7-850E-3DC0DDFAEDF3Q33879677-B66622EF-7699-4754-8867-7E62C9F5D2A1Q33888328-68B74EDC-7621-4128-A0A6-2633385CDB97Q33889978-EB2AF073-CA4E-4B56-913E-69FD9EAD44B9Q33904600-1D321FBF-E120-4EDD-8957-EA4903722468Q33907807-35598962-C348-4856-A96F-B393409E3968Q33909660-A5F12B48-EFFF-4AAD-96B9-82FC3192FF91Q33925916-03CE4EF8-75EA-4750-9E63-92273B12EDD3Q34348061-B676965F-D92C-4C85-BF40-C782A8ECDA62Q34369288-624AB8F9-ECE5-4934-AA8D-F3D9A5F2C01AQ34436487-CF7E55B7-E2E8-4126-98AF-78F3ED19F9C0Q34468157-ECC0A82F-4DEF-431A-8CAD-9847D4C5DE9FQ34480451-BD368A42-2A9D-4535-8EE4-C6EF81C193ECQ34602823-B34A3728-FA96-4435-ADD9-0AFD441DF702Q35091823-8961A9EC-6657-4BBD-8C1D-FA91D69C9D71Q35098539-66311978-15A5-45A2-80DC-E51F64A06063Q35405154-7D4F3106-2002-428F-B7E0-08423622F984Q35819638-6035149A-B4D4-402F-AE16-0B17BC849A6EQ35829888-0DA5E1E9-AF4F-49D0-85E3-E3F93E97789DQ35844833-253F54AC-D194-4BB1-A353-71E7ACEDD4E0Q35902748-4AE77382-DB06-4AE2-8940-474AAAC2F582
P2860
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@en
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@nl
type
label
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@en
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@nl
prefLabel
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@en
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@nl
P2093
P50
P1433
P1476
Mass spectrometry-based metabo ...... and ovarian borderline tumors.
@en
P2093
Dominique Könsgen
Jalid Sehouli
Jan Budczies
Peter Tablack
Wilko Weichert
P304
10795-10804
P356
10.1158/0008-5472.CAN-06-0755
P407
P577
2006-11-01T00:00:00Z